More on SPPI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- Dividends

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SPPI Balance Sheet

Click line-items for a historical chart and %
Current Assets:
Cash and cash equivalents 156.31M
Marketable securities 3.47M
Accounts receivable, net of allowance for doubtful accounts of $630 and $339, respectively 49.48M
Inventories, net 13.52M
Prepaid expenses and other current assets 3.21M
Total current assets 235.19M
Investments
Property and equipment, net 1.54M
Intangible assets, net
Other assets 12.58M
TOTAL ASSETS 499.16M
Current Liabilities:
Accounts payable and other accrued obligations 79.84M
Accrued compensation and related expenses
Deferred revenue 156K
Common stock warrant liability
Accrued drug development costs 3.12M
Total current liabilities 89.98M
Capital lease obligations
Deferred revenue and other credits--less current portion
Zevalin related contingent obligations 5.97M
Total liabilities 217.55M
Commitments and contingencies 0
Stockholders' Equity:
Preferred stock value 0
Common stock, $0.001 par value--175,000,000 shares authorized; 52,947,221 and 51,459,284 issued and outstanding at June 30, 2011 and December 31, 2010, respectively 64K
Additional paid-in capital 518.14M
Accumulated other comprehensive loss 894K
Accumulated deficit -237.62M
Total stockholders' equity 281.61M
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY 499.16M
Series E convertible preferred stock
Stockholders' Equity:
Preferred stock value 0